Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
LANCET GASTROENTEROLOGY & HEPATOLOGY, vol.3, no.6, pp.383-403, 2018 (SCI-Expanded, Scopus)
- Publication Type: Article / Article
- Volume: 3 Issue: 6
- Publication Date: 2018
- Doi Number: 10.1016/s2468-1253(18)30056-6
- Journal Name: LANCET GASTROENTEROLOGY & HEPATOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Page Numbers: pp.383-403
- Istanbul University Affiliated: No
Abstract
Background The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate viral hepatitis by 2030. Although no virological cure exists for hepatitis B virus (HBV) infection, existing therapies to control viral replication and prophylaxis to minimise mother-to-child transmission make elimination of HBV feasible. We aimed to estimate the national, regional, and global prevalence of HBsAg in the general population and in the population aged 5 years in 2016, as well as coverage of prophylaxis, diagnosis, and treatment.